Tarsus Pharmaceuticals, Inc.

Nasdaq TARS · Irvine, CA

Works in Dermatology · Infectious disease · Ophthalmology

Tarsus Pharmaceuticals, Inc. is a clinical trial sponsor based in Irvine, CA, listed as Nasdaq TARS. It has 3 active clinical trials with 909 planned participants, in Dermatology, Infectious disease and Ophthalmology. Since 2021 it has completed 9 trials and stopped 0 early.

Trial track record · since 2021

3Active trials909 planned participants
9Completed3 with results posted
0Stopped early0% of finished trials

Financials · Nasdaq TARS

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 3 active trials

StageTrialStatus

On the market

1 approved drug application with a product on the market.

Questions about Tarsus Pharmaceuticals, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-21.

Approve Suite is not affiliated with Tarsus Pharmaceuticals, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.